Get the latest Science News and Discoveries

Drug that cuts breast cancer risk set for wider use in UK


Get the Android app

Or read this on New Scientist

Read more on:

Photo of wider use

wider use

Photo of breast cancer risk

breast cancer risk

Photo of Drug


Related news:

News photo

Drug that can halve breast cancer risk offered to 289,000 women in England

News photo

FDA approves the first treatment for nasopharyngeal carcinoma, a rare cancer that originates in the nasopharynx. The drug (toripalimab-tpzi) is a next-generation, programmed death receptor-1 monoclonal antibody. Because of the tumor's location (behind the nose), surgery is not usually an option.

News photo

Scientists Investigating Alzheimer’s Drug Faulted in Leaked Report